🔔 آپدیت گایدلاین NIH در درمان کووید ١٩
موارد جدید تغییر 👇👇
✅ The Panel recommends against the use of chloroquine or hydroxychloroquine for the treatment of COVID-19 in hospitalized patients (AI).
✅ In nonhospitalized patients, the Panel recommends against the use of chloroquine or hydroxychloroquine for the treatment of COVID-19, except in a clinical trial (AI).
✅ The Panel recommends against the use of anti-IL-6 receptor monoclonal antibodies (e.g., sarilumab, tocilizumab) or an anti-IL-6 monoclonal antibody (siltuximab) for the treatment of COVID-19, except in a clinical trial (BI).
✅ The Panel recommends against the use of "ivermectin" for the treatment of COVID-19, except in a clinical trial (AIII)
شرح و منبع خبر : https://bit.ly/2G7ewF1
@MMT_IRAN
موارد جدید تغییر 👇👇
✅ The Panel recommends against the use of chloroquine or hydroxychloroquine for the treatment of COVID-19 in hospitalized patients (AI).
✅ In nonhospitalized patients, the Panel recommends against the use of chloroquine or hydroxychloroquine for the treatment of COVID-19, except in a clinical trial (AI).
✅ The Panel recommends against the use of anti-IL-6 receptor monoclonal antibodies (e.g., sarilumab, tocilizumab) or an anti-IL-6 monoclonal antibody (siltuximab) for the treatment of COVID-19, except in a clinical trial (BI).
✅ The Panel recommends against the use of "ivermectin" for the treatment of COVID-19, except in a clinical trial (AIII)
شرح و منبع خبر : https://bit.ly/2G7ewF1
@MMT_IRAN
Comments
Be the first to add a comment
Log in to comment